Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

National Institutes of Health Nationwide (Federal)

Tell us about your organization and we'll show you whether this grant fits, and why.

Free to start. No credit card required.

Deadline

December 23, 2027

Region

Nationwide (Federal)

Funder type

Federal Government

For

Nonprofits & businesses

Sectors

Health & Human Services

About this program

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) — U.S. federal funding opportunity (RFA-HL-26-017) from National Institutes of Health. See grants.gov for full eligibility and details.

Official program page Last verified October 5, 2026 by the Happy Grants engine

Is this grant worth your time?

Create a free account and Happy Grants scores this program, and 2,300+ others, against your organization’s profile in about a minute, with the reasons explained.

See your match score, free

Similar grants